The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
Natera, Inc. | Common Stock | 632307104 | 13,751 | 1,550,280 | SH | SOLE | 1,550,280 | 0 | 0 | ||
Mirna Therapeutics, Inc. | Common Stock | 60470J103 | 6,515 | 2,974,812 | SH | SOLE | 2,974,812 | 0 | 0 | ||
Versartis, Inc. | Common Stock | 92529L102 | 33,376 | 1,563,260 | SH | SOLE | 1,563,260 | 0 | 0 | ||
Innocoll Holdings PLC | Ordinary Shares | G4783X105 | 2,356 | 2,103,173 | SH | SOLE | 2,103,173 | 0 | 0 | ||
Aclaris Therapeutics, Inc. | Common Stock | 00461U105 | 45,907 | 1,539,480 | SH | SOLE | 1,539,480 | 0 | 0 | ||
Auris Medical Holding AG | Common Shares | H03579101 | 7,193 | 7,818,175 | SH | SOLE | 7,818,175 | 0 | 0 | ||
Histogenics Corporation | Common Stock | 43358V109 | 3,593 | 2,077,040 | SH | SOLE | 2,077,040 | 0 | 0 | ||
Sophiris Bio Inc. | Common Stock | 83578Q209 | 566 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
Spark Therapeutics, Inc. | Common Stock | 84652J103 | 37,308 | 699,430 | SH | SOLE | 699,430 | 0 | 0 | ||
ObsEva SA | Common Stock | H5861P103 | 39,034 | 3,749,623 | SH | SOLE | 3,749,623 | 0 | 0 |